[The efficacy of Veinobiase in venous disorders presented in women taking estroprogesterone agents (a statistical study of 2,295 patients)].
The authors tryed by a statistical study to evaluate the efficacy of aphlebotinic therapy in venous diseases induced or aggravated by estroprogestative contraception. During this study, it emerged that the induced functional venous problems were quite virtually corrected by this treatment.
Levardon
M
M
Service de Gynécologie-Obstétrique, Hôpital Beaujon, Clichy.
Vin
F
F
Allaert
F A
FA
D000328:Adult; D000872:Anthocyanins / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects* / Q000145:classification; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007866:Leg / Q000098:blood supply; D008094:Lithium / Q000627:therapeutic use*; D012503:Saponins / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000188:drug therapy / Q000503:physiopathology; D013997:Time Factors; D014648:Varicose Veins / Q000188:drug therapy / Q000503:physiopathology; D014689:Venous Insufficiency / Q000188:drug therapy* / Q000503:physiopathology
D000872:Anthocyanins; D002317:Cardiovascular Agents; D003278:Contraceptives, Oral, Hormonal; D004338:Drug Combinations; D012503:Saponins; C021102:Veinobiase; D008094:Lithium; D001205:Ascorbic Acid
Efficacité de Veinobiase sur les troubles veineux présentés par des femmes sous estroprogestatifs (étude statistique réalisée chez 2,295 patientes).